CereVasc Secures $85 Million in Series C Financing
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 1 day ago
0mins
Source: Newsfilter
- Significant Financing: CereVasc has successfully closed an $85 million Series C financing led by Piper Sandler Merchant Banking, with participation from new investors including Johnson & Johnson Innovation and Medtronic, aimed at funding the completion of the STRIDE pivotal trial and preparing for FDA's PMA submission.
- Clinical Trial Advancement: The proceeds will support the clinical and regulatory development of the eShunt System, with the STRIDE trial designed to evaluate its safety and effectiveness compared to the current standard of care, potentially leading to significant improvements in treatment outcomes for patients with Normal Pressure Hydrocephalus.
- Board Strengthening: Following the financing, the company has strengthened its Board of Directors by adding Kevin Conroy as Lead Independent Director, Christopher Geyen as Chair of the Audit Committee, and Tom Schnettler representing new Series C investors, enhancing governance to support future growth.
- Market Potential: The eShunt System aims to provide a minimally invasive treatment option, with CEO Dan Levangie stating that this financing marks a critical step towards commercialization, reflecting a strong commitment to addressing patient needs and improving quality of life.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy PIPR?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on PIPR
Wall Street analysts forecast PIPR stock price to rise
1 Analyst Rating
1 Buy
0 Hold
0 Sell
Moderate Buy
Current: 77.060
Low
386.00
Averages
386.00
High
386.00
Current: 77.060
Low
386.00
Averages
386.00
High
386.00
About PIPR
Piper Sandler Companies is an investment bank and institutional securities firm, serving corporations, private equity groups, public entities, non-profit entities, and institutional investors in the United States and internationally. The Company provides products and services, including financial advisory services; equity and debt capital markets products; public finance services; institutional brokerage services; fundamental equity and macro research services; fixed income services; and alternative asset management strategies. It offers equity and fixed income advisory and trade execution services for institutional investors, corporations, and government and non-profit entities. Its segment provides investment banking services, institutional sales and trading services for various equity and fixed income products, and research services. It operates alternative asset management funds in merchant banking and healthcare to invest firm capital and manage capital from outside investors.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
CereVasc Secures $85 Million in Series C Financing
- Significant Financing: CereVasc has successfully closed an $85 million Series C financing led by Piper Sandler Merchant Banking, with participation from new investors including Johnson & Johnson Innovation and Medtronic, aimed at funding the completion of the STRIDE pivotal trial and preparing for FDA's PMA submission.
- Clinical Trial Advancement: The proceeds will support the clinical and regulatory development of the eShunt System, with the STRIDE trial designed to evaluate its safety and effectiveness compared to the current standard of care, potentially leading to significant improvements in treatment outcomes for patients with Normal Pressure Hydrocephalus.
- Board Strengthening: Following the financing, the company has strengthened its Board of Directors by adding Kevin Conroy as Lead Independent Director, Christopher Geyen as Chair of the Audit Committee, and Tom Schnettler representing new Series C investors, enhancing governance to support future growth.
- Market Potential: The eShunt System aims to provide a minimally invasive treatment option, with CEO Dan Levangie stating that this financing marks a critical step towards commercialization, reflecting a strong commitment to addressing patient needs and improving quality of life.
See More
Take-Two Interactive Set for Boost from Grand Theft Auto VI Release
- Market Expectations Rise: Piper Sandler initiated coverage of Take-Two Interactive Software with an overweight rating and a $280 price target, implying a 23% upside from Monday's close, reflecting strong market anticipation for the release of Grand Theft Auto VI.
- Game Release Impact: Analyst James Callahan noted that Grand Theft Auto VI could be one of the greatest entertainment launches of all time, and despite facing multiple delays, historical performance suggests it will have a positive market response upon release.
- Mobile Business Growth: Piper Sandler also highlighted the improving mobile franchise of Take-Two, coupled with public market scarcity value, which further enhances investor confidence in the company and indicates future growth potential.
- Analyst Consensus: According to LSEG data, 29 out of 31 analysts covering Take-Two have a buy or strong buy rating, indicating strong market confidence in its future performance, despite an 11% decline in stock price in 2026.
See More
Chubb Limited Named Among Top Dividend Stocks to Buy Now
- Analyst Rating Upgrade: Piper Sandler raised its price target for Chubb Limited from $328 to $340 while maintaining a Neutral rating, reflecting optimism about the overall performance of the insurance sector, particularly the strong underwriting results.
- Market Performance Analysis: Piper Sandler noted that insurance carriers are outperforming brokers, as underwriting performance exceeded expectations, indicating resilience in the insurance industry that may attract more investor interest.
- Wells Fargo Price Target Adjustment: Wells Fargo increased its price target for Chubb from $321 to $333, maintaining an Equal Weight rating, although management's comments on softening conditions in the property insurance market impacted the stock price, showing market caution about future prospects.
- Investment Potential Assessment: While Chubb is viewed as a potentially strong investment, analysts suggest that certain AI stocks may offer greater upside potential and lower downside risk, reflecting a shift in market focus towards different investment sectors.
See More
Consumer Sentiment Hits All-Time Low Amid Inflation Concerns
- Consumer Sentiment Index: The University of Michigan's latest consumer sentiment index has fallen to an all-time low, indicating a pessimistic outlook among consumers that is even worse than during the 2007-2009 financial crisis, highlighting potential economic vulnerabilities.
- Inflation Pressures: Disruptions in the Strait of Hormuz due to Iran have caused oil and gas prices to soar, leading consumers to feel significant economic strain at the pump, which exacerbates concerns about future inflation and could impact spending decisions.
- Social Security COLA Forecast: According to the latest estimates from The Senior Citizens League, the 2027 Social Security cost-of-living adjustment (COLA) could reach 3.9%, marking the highest increase since 2022 and reflecting the direct impact of inflation on seniors' lives.
- Healthcare Cost Concerns: Despite the potential rise in COLA, many retirees may find that the actual increase in their income does not keep pace with rising healthcare costs, as the CPI-W metric used by the Social Security Administration fails to adequately capture the financial pressures faced by seniors.
See More
U.S. Consumer Sentiment Hits All-Time Low Amid Inflation Concerns
- Consumer Sentiment Plummets: The University of Michigan's latest consumer sentiment index reveals that U.S. consumer confidence has reached an all-time low, worse than during the 2007-2009 financial crisis and the early days of the COVID-19 pandemic, indicating a grim economic outlook.
- Inflationary Pressures Intensify: Despite the U.S. economy not being in recession, rising inflation due to post-COVID price surges and tariffs imposed by Trump has heightened consumer concerns about future inflation, particularly as oil prices soar due to conflicts in Iran, directly impacting daily expenses.
- Social Security COLA Forecast Increased: The Senior Citizens League estimates that the 2027 Social Security cost-of-living adjustment (COLA) will be 3.9%, marking the third-highest increase in 15 years, reflecting the ongoing trend of rising inflation.
- Retirees Face Challenges: While the COLA increase may help offset rising product prices, fixed-income retirees may still experience economic strain as costs for essentials like healthcare, housing, and insurance rise faster than overall economic prices, making the
See More
Rising Inflation Drives Value Stocks Recovery
- Value Stock Recovery: The iShares Russell 1000 Value ETF (IWD) has risen over 48% in the past five years, while its growth counterpart, IWF, has nearly doubled, indicating a renewed investor interest in value stocks amid rising inflation, which may further boost their performance.
- Sector Performance Disparity: In 2023, the S&P 500 energy sector surged 30%, while healthcare fell 4.5%, consumer staples rose 10%, and materials increased by 9.5%, highlighting the growing appeal of cyclical value stocks, particularly in energy and consumer sectors under inflationary pressures.
- Economic Growth Expectations: Real GDP is projected to grow by 2.1% in 2025 and increase to 2.4% in 2026, with the Atlanta Fed forecasting growth above 4% in the second quarter, suggesting robust economic performance under inflation, which may further support value stocks.
- Rising Concentration in Tech Stocks: Despite inflation, tech stocks are experiencing a cyclical boom, particularly in semiconductors and AI infrastructure, with the S&P 500 rising about 5% since mid-April, indicating that investor concentration in tech may limit further upside due to associated risks.
See More
CereVasc Secures $85 Million in Series C Financing
- Significant Financing: CereVasc has successfully closed an $85 million Series C financing led by Piper Sandler Merchant Banking, with participation from new investors including Johnson & Johnson Innovation and Medtronic, aimed at funding the completion of the STRIDE pivotal trial and preparing for FDA's PMA submission.
- Clinical Trial Advancement: The proceeds will support the clinical and regulatory development of the eShunt System, with the STRIDE trial designed to evaluate its safety and effectiveness compared to the current standard of care, potentially leading to significant improvements in treatment outcomes for patients with Normal Pressure Hydrocephalus.
- Board Strengthening: Following the financing, the company has strengthened its Board of Directors by adding Kevin Conroy as Lead Independent Director, Christopher Geyen as Chair of the Audit Committee, and Tom Schnettler representing new Series C investors, enhancing governance to support future growth.
- Market Potential: The eShunt System aims to provide a minimally invasive treatment option, with CEO Dan Levangie stating that this financing marks a critical step towards commercialization, reflecting a strong commitment to addressing patient needs and improving quality of life.
See More
Take-Two Interactive Set for Boost from Grand Theft Auto VI Release
- Market Expectations Rise: Piper Sandler initiated coverage of Take-Two Interactive Software with an overweight rating and a $280 price target, implying a 23% upside from Monday's close, reflecting strong market anticipation for the release of Grand Theft Auto VI.
- Game Release Impact: Analyst James Callahan noted that Grand Theft Auto VI could be one of the greatest entertainment launches of all time, and despite facing multiple delays, historical performance suggests it will have a positive market response upon release.
- Mobile Business Growth: Piper Sandler also highlighted the improving mobile franchise of Take-Two, coupled with public market scarcity value, which further enhances investor confidence in the company and indicates future growth potential.
- Analyst Consensus: According to LSEG data, 29 out of 31 analysts covering Take-Two have a buy or strong buy rating, indicating strong market confidence in its future performance, despite an 11% decline in stock price in 2026.
See More
Chubb Limited Named Among Top Dividend Stocks to Buy Now
- Analyst Rating Upgrade: Piper Sandler raised its price target for Chubb Limited from $328 to $340 while maintaining a Neutral rating, reflecting optimism about the overall performance of the insurance sector, particularly the strong underwriting results.
- Market Performance Analysis: Piper Sandler noted that insurance carriers are outperforming brokers, as underwriting performance exceeded expectations, indicating resilience in the insurance industry that may attract more investor interest.
- Wells Fargo Price Target Adjustment: Wells Fargo increased its price target for Chubb from $321 to $333, maintaining an Equal Weight rating, although management's comments on softening conditions in the property insurance market impacted the stock price, showing market caution about future prospects.
- Investment Potential Assessment: While Chubb is viewed as a potentially strong investment, analysts suggest that certain AI stocks may offer greater upside potential and lower downside risk, reflecting a shift in market focus towards different investment sectors.
See More
Consumer Sentiment Hits All-Time Low Amid Inflation Concerns
- Consumer Sentiment Index: The University of Michigan's latest consumer sentiment index has fallen to an all-time low, indicating a pessimistic outlook among consumers that is even worse than during the 2007-2009 financial crisis, highlighting potential economic vulnerabilities.
- Inflation Pressures: Disruptions in the Strait of Hormuz due to Iran have caused oil and gas prices to soar, leading consumers to feel significant economic strain at the pump, which exacerbates concerns about future inflation and could impact spending decisions.
- Social Security COLA Forecast: According to the latest estimates from The Senior Citizens League, the 2027 Social Security cost-of-living adjustment (COLA) could reach 3.9%, marking the highest increase since 2022 and reflecting the direct impact of inflation on seniors' lives.
- Healthcare Cost Concerns: Despite the potential rise in COLA, many retirees may find that the actual increase in their income does not keep pace with rising healthcare costs, as the CPI-W metric used by the Social Security Administration fails to adequately capture the financial pressures faced by seniors.
See More
U.S. Consumer Sentiment Hits All-Time Low Amid Inflation Concerns
- Consumer Sentiment Plummets: The University of Michigan's latest consumer sentiment index reveals that U.S. consumer confidence has reached an all-time low, worse than during the 2007-2009 financial crisis and the early days of the COVID-19 pandemic, indicating a grim economic outlook.
- Inflationary Pressures Intensify: Despite the U.S. economy not being in recession, rising inflation due to post-COVID price surges and tariffs imposed by Trump has heightened consumer concerns about future inflation, particularly as oil prices soar due to conflicts in Iran, directly impacting daily expenses.
- Social Security COLA Forecast Increased: The Senior Citizens League estimates that the 2027 Social Security cost-of-living adjustment (COLA) will be 3.9%, marking the third-highest increase in 15 years, reflecting the ongoing trend of rising inflation.
- Retirees Face Challenges: While the COLA increase may help offset rising product prices, fixed-income retirees may still experience economic strain as costs for essentials like healthcare, housing, and insurance rise faster than overall economic prices, making the
See More
Rising Inflation Drives Value Stocks Recovery
- Value Stock Recovery: The iShares Russell 1000 Value ETF (IWD) has risen over 48% in the past five years, while its growth counterpart, IWF, has nearly doubled, indicating a renewed investor interest in value stocks amid rising inflation, which may further boost their performance.
- Sector Performance Disparity: In 2023, the S&P 500 energy sector surged 30%, while healthcare fell 4.5%, consumer staples rose 10%, and materials increased by 9.5%, highlighting the growing appeal of cyclical value stocks, particularly in energy and consumer sectors under inflationary pressures.
- Economic Growth Expectations: Real GDP is projected to grow by 2.1% in 2025 and increase to 2.4% in 2026, with the Atlanta Fed forecasting growth above 4% in the second quarter, suggesting robust economic performance under inflation, which may further support value stocks.
- Rising Concentration in Tech Stocks: Despite inflation, tech stocks are experiencing a cyclical boom, particularly in semiconductors and AI infrastructure, with the S&P 500 rising about 5% since mid-April, indicating that investor concentration in tech may limit further upside due to associated risks.
See More
